U.S. flag

An official website of the United States government

NM_005633.4(SOS1):c.3330G>C (p.Ser1110=) AND RASopathy

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Apr 18, 2017
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000520406.8

Allele description [Variation Report for NM_005633.4(SOS1):c.3330G>C (p.Ser1110=)]

NM_005633.4(SOS1):c.3330G>C (p.Ser1110=)

Gene:
SOS1:SOS Ras/Rac guanine nucleotide exchange factor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p22.1
Genomic location:
Preferred name:
NM_005633.4(SOS1):c.3330G>C (p.Ser1110=)
Other names:
NM_005633.3(SOS1):c.3330G>C
HGVS:
  • NC_000002.12:g.38995139C>G
  • NG_007530.1:g.130325G>C
  • NM_001382394.1:c.3309G>C
  • NM_001382395.1:c.3330G>C
  • NM_005633.4:c.3330G>CMANE SELECT
  • NP_001369323.1:p.Ser1103=
  • NP_001369324.1:p.Ser1110=
  • NP_005624.2:p.Ser1110=
  • NP_005624.2:p.Ser1110=
  • LRG_754t1:c.3330G>C
  • LRG_754:g.130325G>C
  • LRG_754p1:p.Ser1110=
  • NC_000002.11:g.39222280C>G
  • NC_000002.11:g.39222280C>G
  • NM_005633.3:c.3330G>C
  • p.Ser1110Ser
Links:
dbSNP: rs146383828
NCBI 1000 Genomes Browser:
rs146383828
Molecular consequence:
  • NM_001382394.1:c.3309G>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382395.1:c.3330G>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_005633.4:c.3330G>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
RASopathy
Synonyms:
rasopathies; Noonan spectrum disorder
Identifiers:
MONDO: MONDO:0021060; MedGen: C5555857

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000616507ClinGen RASopathy Variant Curation Expert Panel
reviewed by expert panel

(ClinGen RASopathy ACMG Specifications v1)
Likely benign
(Apr 18, 2017)
germlinecuration

Citation Link,

SCV000659146Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely benign
(Dec 27, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From ClinGen RASopathy Variant Curation Expert Panel, SCV000616507.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The filtering allele frequency of the c.3330G>C (p.Ser1110=) variant in the SOS1 gene is 0.0382% (8/10406) of African chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as likely benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BS1; PMID:29493581)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV000659146.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024